Want to join the conversation?
$CELG Form 4: James Loughlin, Director of Celgene Corporation exercised 733 stock options, one-third of RSUs are granted to reporting person on July 1, 2014 vested and settled for shares of the company's common stock on July 1, 2015. Post transaction, he now owns 21,885 shares.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.